États-Unis · Plateformes & données · Stocktwits

Meta's Muse AI Momentum Wins Over Analysts — But $140B Spending Outlook Raises Funding Questions

Publié par Stocktwits · États-Unis il y a 8 h

Meta Platforms (META) drew mixed price-target revisions from the Street on Thursday as analysts welcomed early momentum in its Muse artificial intelligence (AI) products but…

Lire l'article complet sur Stocktwits Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stocktwits.com)

Meta's Muse AI Momentum Wins Over Analysts — But $140B Spending Outlook Raises Funding Questions

À lire aussi

Fusion Fuel Green deal cuts QIND’s Al Shola Gas payments due to $7M

A Recession Is Coming Eventually, and History Says There's a Major Silver Lining for Investors

Markets are pricing in long-term AI winners. This veteran investor says history proves customers win more than innovators.

Best Tech Stocks Right Now

Cantor Fitzgerald reiterates Texas Instruments stock neutral rating

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Meta's Muse AI Momentum Wins Over Analysts — But $140B Spending Outlook Raises Funding Questions

Partager

À lire aussi

Fusion Fuel Green deal cuts QIND’s Al Shola Gas payments due to $7M

A Recession Is Coming Eventually, and History Says There's a Major Silver Lining for Investors

Markets are pricing in long-term AI winners. This veteran investor says history proves customers win more than innovators.

Best Tech Stocks Right Now

Cantor Fitzgerald reiterates Texas Instruments stock neutral rating

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment